Jeff Moore

Jeff Moore supports the National Institute on Drug Abuse (NIDA) in executing mission-critical procurement activities aligned with its mandate to advance scientific research on substance use disorders. While his formal title is not specified, his role centers on managing complex research-support acquisitions, including laboratory instrumentation, analytical services, and specialized facility upgrades. He facilitates the acquisition of technical resources essential to neurobiological and behavioral research, ensuring that funded institutions have access to state-of-the-art capabilities for translational science. His work directly enables NIDA’s strategic goals by securing the infrastructure and services necessary to convert laboratory findings into clinical and public health applications. Moore maintains consistent procurement relationships with leading academic and research institutions, including The McLean Hospital Corporation, the University of Maryland, Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These partnerships reflect a pattern of awarding contracts to high-capacity research entities capable of delivering sophisticated scientific services, from neuroimaging and biomarker analysis to clinical trial support. His contracting approach prioritizes institutional expertise and technical capacity over commercial vendors, emphasizing collaborative, mission-driven research ecosystems. His procurement portfolio exhibits a strong preference for open competition, with 93.8% of awards issued without socioeconomic set-asides, indicating a focus on technical merit and research capability rather than socioeconomic targeting. While women-owned small businesses account for 6.3% of awards, there is minimal reliance on 8(a), HUBZone, or SDVOSB programs, reflecting a research-centric acquisition strategy driven by domain expertise. Moore’s primary NAICS focus includes analytical laboratory instrument manufacturing, testing laboratories and services, and electronic equipment repair—reflecting deep engagement with precision research tools, clinical diagnostics, and specialized lab infrastructure. He routinely procures high-end analytical instruments, blood and organ banking systems, and facility finishing services critical to maintaining compliant, high-throughput research environments. His technical domain expertise lies at the intersection of neuroscience, clinical diagnostics, and laboratory operations.